10:31 ETHyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsight
21:01 ETKaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan
Kasumigaseki Capital partners with Taisho Pharmaceutical on heatstroke prevention project for construction workers